A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis
A Banzhoff, P Nacci, A Podda - Gerontology, 2003 - karger.com
Background: The elderly are at a higher risk of morbidity and mortality associated with
influenza infection than younger adults, but get less protection from conventional …
influenza infection than younger adults, but get less protection from conventional …
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
SE Frey, MR Aplasca-De Los Reyes, H Reynales… - Vaccine, 2014 - Elsevier
Aim Adjuvanted influenza vaccines can overcome the poor antibody response of
conventional non-adjuvanted vaccines in the elderly. We evaluated the immunogenicity …
conventional non-adjuvanted vaccines in the elderly. We evaluated the immunogenicity …
[HTML][HTML] Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis
A Domnich, L Arata, D Amicizia, J Puig-Barberà… - Vaccine, 2017 - Elsevier
Background In the elderly, traditional influenza inactivated vaccines are often only modestly
immunogenic, owing to immunosenescence. Given that adjuvantation is a means of …
immunogenic, owing to immunosenescence. Given that adjuvantation is a means of …
Comparative immunogenicity of enhanced seasonal influenza vaccines in older adults: a systematic review and meta-analysis
TWY Ng, BJ Cowling, HZ Gao… - The Journal of …, 2019 - academic.oup.com
Background A number of enhanced influenza vaccines have been developed for use in
older adults, including high-dose, MF59-adjuvanted, and intradermal vaccines. Methods We …
older adults, including high-dose, MF59-adjuvanted, and intradermal vaccines. Methods We …
Long‐term and cross‐reactive immunogenicity of inactivated trivalent influenza vaccine in the elderly: MF59‐adjuvanted vaccine versus unadjuvanted vaccine
JY Song, HJ Cheong, JY Noh, YB Seo… - Journal of medical …, 2013 - Wiley Online Library
Elderly people are at great risk for influenza‐related serious complications. However,
influenza vaccine‐induced antibodies are believed to decline more rapidly in the elderly …
influenza vaccine‐induced antibodies are believed to decline more rapidly in the elderly …
Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly
S De Donato, D Granoff, M Minutello, G Lecchi… - Vaccine, 1999 - Elsevier
Safety and immunogenicity of the influenza vaccine adjuvanted with MF59 (FLUADTM) were
compared to those of a non adjuvanted subunit vaccine in elderly subjects during three …
compared to those of a non adjuvanted subunit vaccine in elderly subjects during three …
Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly
The influenza vaccination is known as the most effective method for preventing influenza
infection and its complications in the elderly. Conventional subunit (Agrippal S1; Novartis) …
infection and its complications in the elderly. Conventional subunit (Agrippal S1; Novartis) …
[HTML][HTML] Comparative effectiveness of adjuvanted versus high-dose seasonal influenza vaccines for older adults: a systematic review and meta-analysis
A Domnich, C de Waure - International Journal of Infectious Diseases, 2022 - Elsevier
Objectives MF59-adjuvanted standard-dose and nonadjuvanted high-dose seasonal
influenza vaccines have been developed to protect the elderly at high risk of severe …
influenza vaccines have been developed to protect the elderly at high risk of severe …
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59® adjuvant: Results from a dose-finding clinical trial in older adults
G Della Cioppa, U Nicolay, K Lindert… - Human vaccines & …, 2012 - Taylor & Francis
Background: MF59-adjuvanted influenza vaccines have superior immunogenicity in older
adults compared with non-adjuvanted vaccines. We assessed whether changing formulation …
adults compared with non-adjuvanted vaccines. We assessed whether changing formulation …
Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults
S Frey, G Poland, S Percell, A Podda - Vaccine, 2003 - Elsevier
The adjuvanted influenza vaccine FLUAD™ is composed of subunit influenza antigens
combined with the MF59-adjuvant emulsion. The vaccine was developed primarily for use in …
combined with the MF59-adjuvant emulsion. The vaccine was developed primarily for use in …
相关搜索
- older adults influenza vaccines
- meta analysis influenza vaccines
- safety and immunogenicity influenza vaccine
- older adults meta analysis
- chronic diseases influenza vaccine
- chronic diseases meta analysis
- chronic diseases immune response
- immune response meta analysis
- immune response influenza vaccine
- elderly subjects influenza vaccine
- elderly subjects safety and immunogenicity
- adjuvanted vaccine long term
- full dose influenza vaccines
- comparison of the safety influenza vaccine
- comparison of the immunogenicity influenza vaccines
- long term influenza vaccine